Skip to content

MEDICOL

Active
Private limited company· 5 yrs active
Rue Franklin Roosevelt 301 ·4870 Trooz, Belgium
KBO/BCE: BE 0760.530.478
Watch Print / PDF
Full dossier in preparation

Checked processes every Belgian company, act by act, from the Belgian Official Gazette. The data below is real and verified, this company's full, act-by-act verified dossier is still being assembled.

Process with priority Sign in free to move this company to the front.
Age5 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of MEDICOL is 2.4% (moderate). The 2025 annual accounts show equity of €93k and a net result of €77k. Equity is growing by ~23.4% per year across the filed fiscal years. The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 5 annual accounts.

Signals

1 signal · with evidence
Consistently profitable
Positive net result in the two most recent financial years (2024 and 2025).
View the result trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Trust signals

2 signals
More than 3 years active
Founded in 2020, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No administrative flags

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
2.4% Moderate
0%0,5%1,5%4%10%≥25%
Young company +No NACE activity registered +Annual accounts: healthy financial profile

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€77k+20.8%
Working capital€18k+64.0%

Annual accounts & ratios

Source: NBB · 2025
Annual accounts filed on 05-05-2026 with the NBB · fiscal year 2025 · micro
€0€25k€50k€75k€100kOperating result 2021: €71k€71kNet result 2021: €53k€53kOperating result 2022: €32k€32kNet result 2022: €28k€28kOperating result 2023: €68k€68kNet result 2023: €54k€54kOperating result 2024: €89k€89kNet result 2024: €64k€64kOperating result 2025: €99k€99kNet result 2025: €77k€77k20212022202320242025
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing Equity: growth of ~23.4%/year over 5 fiscal years, indicative, assuming unchanged policy.
€0€100k€200k€300k2026: €142k (€119k - €166k)2027: €176k (€138k - €214k)2028: €217k (€165k - €269k)2021: €37k2022: €64k2023: €95k2024: €93k2025: €93k20212022202320242025202620272028
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

EBITDA
€113k
+10.9% 21-25
Net profit
€77k
+20.8% 21-25
Cash flow
€92k
+18.2% 21-25
Total assets
€193k
+37.3% 21-25
Equity
€93k
0.0% 21-25
Working capital
€18k
+64.0% 21-25
Income taxes
€21k
-12.0% 21-25
Dividends
€77k
+17.6% 21-25
Debt
€99k
+111.6% 21-25
Debt ≤ 1y
€91k
+173.9% 21-25
Debt > 1y
€8k
-38.4% 21-25
Current ratio
1.20
-9.9% 21-25
Quick ratio
1.20
-9.9% 21-25
Solvency
48.5%
-27.1% 21-25
Debt / equity
1.06
+111.6% 21-25
ROE
82.8%
+20.8% 21-25
ROA
40.2%
-12.0% 21-25
Interest coverage
116.04
+43.3% 21-25
Figures by fiscal year
Fiscal year2025
Revenue-
EBITDA€113k
Net profit€77k
Cash flow€92k
Staff costs-
Income taxes€21k
Dividends€77k
Total assets€193k
Equity€93k
Debt€99k
of which ≤ 1y€91k
of which > 1y€8k
Working capital€18k
Employees (FTE)-
Ratios (computed)
2025
Current ratio1.20
Quick ratio1.20
Working capital ratio9.3%
Solvency48.5%
Debt / equity1.06
Long-term debt ratio0.09
Interest coverage116.04
Gross margin-
Net margin-
ROA40.2%
ROE82.8%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2025
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2025
Balance sheet, Assets
TOTAL ASSETS 20/58€193k
Fixed assets 21/28€84k
Tangible fixed assets 22/27€84k
Current assets 29/58€109k
Amounts receivable within one year 40/41€6k
Cash & bank 54/58€101k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€193k
Equity 10/15€93k
Contributions / capital 10/11€2k
Reserves 13€91k
Accumulated profits (losses) 14€0
Amounts payable 17/49€99k
Amounts payable after one year 17€8k
Amounts payable within one year 42/48€91k
Trade debts payable within one year 44€118
Income statement
Gross operating margin 9900€114k
Operating result 9901€99k
Financial income 75€37
Financial charges 65€977
Result before taxes 9903€98k
Income taxes 67/77€21k
Net result for the period 9904€77k
Result to be appropriated 9905€77k
You're seeing the latest fiscal year only. Unlock 4 prior years (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2025 · computed
86 / 100 Excellent
050100
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.

See plans →
Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.

Locations & real estate

Registered office

on the map · from the address register
seat.Municipality exact location from the address register
4 companies at this address See who is registered here
Parcels1
Ground area183 m²
Buildings1
Building footprint54 m²
Volume (LiDAR)511 m³
Tallest building10.8 m · ±3 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
62041A0006/00T002 Wallonia 183 m² 1 · 54 m² 10.8 m · 3 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgian State Gazette · acts

No structured acts for this company yet

That means one of two things: the company has published no company deeds, or its deeds are still queued for reading. The insolvency signals above come from a separate source and are complete.

Analysis

Snowflake analysis

financial profile on 5 axes
Health86Profitability100Solvency76Growth78Stability94
87 / 100

Exceptional profile, strong across almost every axis.

All 5 axes are computed from data Checked has read.

Health 86
Profitability 100
Solvency 76
Growth 78
Stability 94

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Company registry

Company registry (CBE)

Crossroads Bank
Names & trade names
Legal nameFR MEDICOL
Registered office
Rue Franklin Roosevelt 301
4870 Trooz, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.